Gemfrac Injection
Marketer
Alkem Laboratories Ltd
Salt Composition
Teriparatide (600mcg)
Overview Gemfrac Injection
Parathyroid hormone therapy, specifically Gemfrac Injection, is a synthetic treatment for severe osteoporosis in men and postmenopausal women at heightened fracture risk. This medication stimulates bone growth, thereby increasing bone density and reducing spinal fracture probability. Gemfrac Injection is administered subcutaneously or by a medical professional. Consistent daily dosing is crucial for optimal efficacy. Treatment typically lasts up to two years, although the physician's recommendations should be followed diligently, regardless of symptom improvement. Refrigerate the medication between 2°C and 8°C. Common adverse effects encompass joint pain, injection site inflammation (pain, swelling, redness), and leg spasms; report persistent or bothersome side effects to your doctor. Prior to commencing therapy, disclose any kidney issues, including kidney stones, as Gemfrac Injection may elevate blood or urine calcium levels. Pregnant or lactating individuals should seek medical counsel before using this medication. Your doctor might order bone density scans to track treatment progress.
Uses of Gemfrac Injection
Brittle bone disease
Major Benefits of Gemfrac Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Gemfrac Injection:
- Joint pain
- Injection site reactions (pain, swelling, redness)
- Nausea
- Leg cramps
How to use Gemfrac Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Gemfrac Injection works:
Gemfrac Injection is a manufactured analog of the naturally occurring parathyroid hormone (PTH). Its mechanism of action involves stimulating osteoblast proliferation and activity, leading to enhanced bone strength and a reduced fracture risk.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when combining Gemfrac Injection with alcohol. Physician consultation is recommended.
PregnancyCONSULT YOUR DOCTOR
The use of Gemfrac Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Physician consultation is advised.
Breast feedingCONSULT YOUR DOCTOR
Data on Gemfrac Injection use while breastfeeding is absent. Seek medical advice from your physician.
DrivingUNSAFE
Administering Gemfrac Injection might reduce attentiveness, impair vision, and induce drowsiness or dizziness. Driving should be avoided if these effects manifest.
KidneyCAUTION
Individuals with kidney impairment should receive Gemfrac Injection cautiously, potentially requiring dosage modification. Physician consultation is advised. Gemfrac Injection is contraindicated for patients exhibiting severe kidney dysfunction.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding Gemfrac Injection's use in individuals with hepatic impairment. Physician consultation is recommended.
What if you forget to take Gemfrac Injection :
Should you forget a Gemfrac Injection dose, administer it at your earliest convenience. However, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Gemfrac Injection
| Label | Value |
|---|---|
| Pharmaceutical Category | Synthetic Parathyroid Hormone Preparations |
| Addictive | None. |
| Type of Medication | Endocrine regulators |



